{"id":856701,"date":"2026-09-22T15:00:14","date_gmt":"2026-09-22T15:00:14","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/856701\/"},"modified":"2026-09-22T15:00:14","modified_gmt":"2026-09-22T15:00:14","slug":"buy-the-dip-on-ge-healthcare-says-needham","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/856701\/","title":{"rendered":"Buy the dip on GE Healthcare, says Needham"},"content":{"rendered":"<p>GE Healthcare is set for a turnaround after a a period of underperformance, according to Needham. The research firm initiated coverage of the med-tech stock with a buy rating. It also assigned a $93 price target to shares, suggesting 43% upside from Monday&#8217;s close. &#8220;Our Bull-Bear analysis of GEHC suggests shares are largely pricing in a Bear case, which creates an attractive risk\/reward,&#8221; analyst David Saxon said Tuesday in a note to clients. &#8220;Further, given GEHC&#8217;s capital book-to-bill&#8217;s correlation with capital growth outlook, we expect AIS growth to accelerate in 2027, which should serve as a source of upside to Street models, which only reflect PCS growth improving.&#8221; Shares of GE Healthcare have fallen nearly 19% year to date as the company has missed earnings expectations and issued lackluster financial outlooks due to supply constraints and other issues. GEHC YTD mountain Shares are down about 21% in 2026. However, the company is expected to post stronger growth in the near future, while its stock should demonstrate &#8220;modest multiple expansion,&#8221; per Needham. In its base case, the investment firm forecasts GE Healthcare Technologies will notch mid-single digit revenue growth and high-single digit earnings per share growth over the next year. It also sees GE Healthcare hitting a price-to-earnings multiple of 17 times its analyst&#8217;s estimates for 2027.\u00a0It currently trades at a forward multiple of 12.6, per FactSet. Needham&#8217;s call falls in line with consensus on the Street. Of the 21 analysts covering GE Healthcare Technologies, 14 have a buy or strong buy on the stock, while seven have a hold rating on it, LSEG data shows.<\/p>\n","protected":false},"excerpt":{"rendered":"GE Healthcare is set for a turnaround after a a period of underperformance, according to Needham. The research&hellip;\n","protected":false},"author":2,"featured_media":856702,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[59],"tags":[122,361818,97,252,253,113,114],"class_list":["post-856701","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health-care","tag-business-news","tag-ge-healthcare-technologies-inc","tag-health","tag-health-care","tag-healthcare","tag-investment-strategy","tag-stock-markets"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/856701","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=856701"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/856701\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/856702"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=856701"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=856701"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=856701"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}